Clinical Trial Update: A Phase II Study of Oxaliplatin in Association With 5FU and Folinic Acid in the Treatment of Subjects With Non-Surgical or Advanced Metastatic Gastric Cancer [Phase 2]

View source ↗

Summary

A Phase II trial evaluated the combination of oxaliplatin with 5-fluorouracil and folinic acid in patients with gastric cancer; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Leucovorin (folinic acid) (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Sanofi | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED